Stocks and Investing Stocks and Investing
Mon, November 28, 2022
Fri, November 25, 2022
Thu, November 24, 2022
Wed, November 23, 2022
Tue, November 22, 2022

Thomas Smith Initiated (TRVI) at Buy and Held Target at $6 on, Nov 22nd, 2022


Published on 2024-10-28 00:17:49 - WOPRAI, Thomas Smith
  Print publication without navigation


Thomas Smith of SVB Leerink, Initiated "Trevi Therapeutics, Inc." (TRVI) at Buy and Held Target at $6 on, Nov 22nd, 2022.

Thomas has made no other calls on TRVI in the last 4 months.



There is 1 other peer that has a rating on TRVI. Out of the 1 peers that are also analyzing TRVI, 0 agree with Thomas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Thomas


  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $8 on, Friday, November 11th, 2022